CCNH and neoplasm: By immunohistochemical analysis of cyclin H expression in 95 tumour specimens of a single centre population we found a high expression of cyclin H (≥ 10% reactive cells) in 24% of the tumours, which correlated well with the risk of malignancy (p = 0.176).